These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 82669)

  • 41. A microscopic method for the evaluation of the bacillary output in sputum of tuberculous patients under chemotherapy.
    Bercea O; Bogdănescu V; Marcian S; Ceicu A
    Scand J Respir Dis; 1969; 50(2):89-100. PubMed ID: 4898946
    [No Abstract]   [Full Text] [Related]  

  • 42. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
    Il'iuna TIa; Zhangireev AA; Sidorenko OA
    Probl Tuberk Bolezn Legk; 2008; (5):20-2. PubMed ID: 18711814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The results of the use of riboxin in the combined treatment of patients with pulmonary tuberculosis].
    Aleksandrova AE; Borisova LE; Vasil'ev AV
    Probl Tuberk; 1989; (9):28-33. PubMed ID: 2511573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Late clinical and functional results in patients after pneumonectomy because of tuberculosis. I. Analysis of the epidemiological and clinical condition in patients before and after pneumonectomy.
    Piekarniak K; Zieliński J
    Pol Med J; 1970; 9(6):1411-21. PubMed ID: 4994233
    [No Abstract]   [Full Text] [Related]  

  • 45. [Possibility of the intensification of tuberculosis chemotherapy and its limits].
    Naito M; Kanai K; Kondo E; Yamashita H; Matsui K
    Kekkaku; 1969 Nov; 44(11):377-93. PubMed ID: 4982567
    [No Abstract]   [Full Text] [Related]  

  • 46. Patterns of delays in diagnosis amongst patients with smear-positive pulmonary tuberculosis at a teaching hospital in Turkey.
    Okur E; Yilmaz A; Saygi A; Selvi A; Süngün F; Oztürk E; Dabak G
    Clin Microbiol Infect; 2006 Jan; 12(1):90-2. PubMed ID: 16460554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sputum smear status at two months and subsequent treatment outcome in new patients with smear-positive pulmonary tuberculosis.
    Salaniponi FM; Christensen JJ; Gausi F; Kwanjana JJ; Harries AD
    Int J Tuberc Lung Dis; 1999 Nov; 3(11):1047-8. PubMed ID: 10587328
    [No Abstract]   [Full Text] [Related]  

  • 48. [Evaluation of care for elderly pulmonary tuberculosis patients].
    Sasaki Y; Yamagishi F; Yagi T; Hashimoto T; Bekku R; Kawasaki T; Shinozaki A
    Kekkaku; 2007 Oct; 82(10):733-9. PubMed ID: 18018597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of aggravating factors on the effectiveness of the treatment of newly detected patients with destructive pulmonary tuberculosis].
    Zozuliak VI
    Vrach Delo; 1988 Jun; (6):54-5. PubMed ID: 3138824
    [No Abstract]   [Full Text] [Related]  

  • 50. [Should chemotherapy for pulmonary tuberculosis be started after the completion of pretreatment sputum examination?].
    Ito K; Aono A; Yoshiyama T; Wada M; Ogata H
    Kekkaku; 2005 Dec; 80(12):735-41. PubMed ID: 16447786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
    Zhangireev AA; Ismailov ShSh; Berikova EM
    Probl Tuberk; 2000; (3):23-5. PubMed ID: 10900979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Conversion of the sputum--only a relative success measurement in the treatment of tuberculosis. Bacteriological study of 614 resection preparations].
    Winter G; Viereck HJ
    Med Welt; 1972 Sep; 23(38):1294-7. PubMed ID: 5078662
    [No Abstract]   [Full Text] [Related]  

  • 54. [Outlook for using a short course of chemotherapy in tuberculosis].
    Anastasatu C; Corlan E
    Probl Tuberk; 1987; (10):31-4. PubMed ID: 3122200
    [No Abstract]   [Full Text] [Related]  

  • 55. [Chemotherapy of tuberculosis with controlled viability of Mycobacteria in the sputum].
    Rudoĭ NM; Erkovskaia OIu
    Probl Tuberk; 1978 May; (5):43-7. PubMed ID: 97658
    [No Abstract]   [Full Text] [Related]  

  • 56. [Logistic analysis on risk factors related to smear positive pulmonary tuberculosis].
    Li XT; Ye LX; Shi LY; Xiao AQ; Hou SY; Wang W; Ye JJ; Tang SW; Zhao HH; Xu HT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):658-60. PubMed ID: 15555385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Proceedings: Results of a controlled trial of intermittent ambulatory therapy of infectious pulmonary tuberculosis with comparison of various maintenance regimens].
    Ganguin HG; Cramer G; Götz J; Holzhauer H; Niegsch G; Sieler H; Velten G; Völker L
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):107-15. PubMed ID: 4203235
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of rifampicin on the L transformation of a mycobacterial population in patients with destructive pulmonary tuberculosis].
    Karachunskiĭ MA; Dorozhkova IR; Chukanov VI; Balta IuE; Kiazimova LM
    Probl Tuberk; 1986; (9):31-4. PubMed ID: 3097632
    [No Abstract]   [Full Text] [Related]  

  • 60. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
    Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
    Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.